Verastem Oncology
VSTM
$11.85
Share price
-0.59%
Change (1 day)
2,862.50%
Change (1 year)
Categories
Revenue for Verastem Oncology (VSTM)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of $2.59 M an increase over the years 2021 revenue that were of $2.05 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Verastem Oncology from 2011 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2023 (TTM)  | N/A | -100% |
| 2022 | $2.59 M | 26.45% |
| 2021 | $2.05 M | -97.68% |
| 2020 | $88.51 M | 407.11% |
| 2019 | $17.45 M | -34.67% |
| 2018 | $26.71 M | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $58.49 B | N/A | 🇺🇸 USA |
 LabCorp LH | $12.30 B | N/A | 🇺🇸 USA |
 GlaxoSmithKline GSK | $38.54 B | N/A | 🇬🇧 UK |
 Curis CRIS | $10.02 M | N/A | 🇺🇸 USA |